Efficacy of azithromycin in severe asthma from the AMAZES randomised trial
Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined.Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Participants who met one of th...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Artigo |
Language: | English |
Published: |
2019
|
Online Access: | https://doi.org/10.1183/23120541.00056-2019 https://openres.ersjournals.com/content/erjor/5/4/00056-2019.full.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!